GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children: A Randomized, Controlled, Pilot Study.

Trial Profile

GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children: A Randomized, Controlled, Pilot Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Oct 2012

At a glance

  • Drugs Exenatide (Primary)
  • Indications Glucose intolerance; Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Nov 2011 Results published in Obesity.
    • 28 Jun 2011 Interim results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
    • 27 Sep 2010 Trial phase changed from IV to II as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top